Abeona Therapeutics falls after quarterly loss, revenue miss
BUZZ-Abeona Therapeutics falls after quarterly loss, revenue miss ** Shares of drugmaker Abeona Therapeutics ABEO.O fall 17.4% to $6.16 in premarket trading
** Co posts Q2 loss of 35 cents per share, compared with a profit of $1.71 per share a year earlier
** Posts Q2 revenue of $11.4 million, below analysts' average estimate of $12.2 million, according to LSEG data
** As of last close, ABEO up 41.6% YTD
(Reporting by Kunal Das in Bengaluru)
Recent news on Abeona Therapeutics
See all newsBrief: Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Ultragenyx rises after FDA nod for rare disorder drug
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce
U.S. STOCKS ON THE MOVE-Cerebras, Madison Square Garden Sports